The main two things I'm waiting for here is news on the cirrhosis of the liver treatments and how they will proceed here in the US.
And, the marketing of their anti aging cream which prompts your own stem cells to regenerate.
Plus, as we get new financials the revenues should continue to grow. And, that is unusual for a company like this. It is rare for this type of company to have revenues at this point. We can thank the sales of the cream in Asia for this. ;)
Market Data 
Markets 
AI
